MAUDE Adverse Event Report: HOLOGIC, INC Biozorb; MARKER, RADIOGRAPHIC, IMPLANTABLE

Model Number	F0202
Medical Device Problem Code	Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes	Erosion (1750); Erythema (1840); Breast Discomfort/Pain (4504); Swelling/ Edema (4577); Abnormal scarring (4896)
Date of Event	06/16/2023
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
Device history record (dhr) review was unable to be conducted for the disposable device as the identification numbers were not provided by the complainant.This report is being submitted pursuant to 21 cfr part 803 based on information made available to hologic through litigation.Consistent with 21 cfr 803.16, the submission of this report is not intended, and shall not be construed, as an admission, acknowledgment, or confirmation by hologic that the device caused or contributed to the reportable event.
Event or Problem Description
Hologic has received correspondence arising from litigation.The litigation alleges that a patient underwent a left breast lumpectomy with a biozorb implant on (b)(6) 2023.It is alleged that in the months following surgery, the patient experienced persistent pain and swelling at the lumpectomy site.It is alleged that on (b)(6) 2024, the area showed erythema and was "mildly swollen." in (b)(6) 2025, it is alleged that the patient presented with "an unusual non-healing wound and drainage at the prior lumpectomy site." it is alleged that "the device was noted to have eroded through the breast tissue." on (b)(6) 2025, it is alleged that the patient was admitted for removal "of a left breast foreign body and placement of a wound vacuum." it is reported that "operative findings confirmed an eroding biozorb device at the lumpectomy site, with excision of the remaining biozorb material and the surrounding scar cavity." this report is being submitted pursuant to 21 cfr part 803 based on information made available to hologic through litigation.Consistent with 21 cfr 803.16, the submission of this report is not intended, and shall not be construed, as an admission, acknowledgment, or confirmation by hologic that the device caused or contributed to the reportable event.

• Brand Name: Biozorb
• Common Device Name: MARKER, RADIOGRAPHIC, IMPLANTABLE
• Manufacturer (Section D): HOLOGIC, INC; 250 campus drive; marlborough MA 01752
• Manufacturer (Section G): HOLOGIC, INC; 250 campus drive; marlborough MA 01752
• Manufacturer Contact: dara smithers ; 600 technology drive; newark, DE 19702
• MDR Report Key: 24606810
• Report Number: 1222780-2026-00121
• Device Sequence Number: 13360562
• Product Code: NEU
• Combination Product (Y/N): N
• Initial Reporter Country: US
• PMA/510(K) Number: K143484
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2023
• Device Explanted Year: 2025
• Serviced by Third Party (Y/N): N
• Reporter Type: Manufacturer
• Report Source: Other,Company Representative
• Type of Report: Initial,Followup
• Report Date (Section B): 09/30/2026

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Health Professional
• Device Model Number: F0202
• Device Catalogue Number: F0202
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: No
• Was the Report Sent to FDA?: No
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 02/16/2026
• Supplement Date Received by Manufacturer: 09/24/2026
• Initial Report FDA Received Date: 03/16/2026
• Supplement Report FDA Received Date: 09/30/2026
• Was Device Evaluated by Manufacturer? (Y/N): No
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Other
• Patient Sex: Unknown